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Abstract
Background: Long QT syndrome (LQTS) is a cardiac disorder characterized by prolonged QT intervals
on electrocardiograms (ECG), ventricular arrhythmias, and sudden death. Clinically, two inherited forms
of LQTS have been defined: autosomal dominant LQTS or Romano-Ward syndrome (RWS) not
associated with deafness and autosomal recessive LQTS or Jervell and Lange-Nielsen syndrome (JLNS)
associated with deafness.
Methods: A Chinese family with both RWS and JLNS was identified. Family members were diagnosed
based on the presence of a prolonged QT interval as seen on a 12-lead ECG and a medical history of
syncope, palpitation, and deafness. Mutational studies in the KCNQ1  potassium channel gene were
performed using direct DNA sequence analysis and restriction length polymorphism analysis.
Results: The proband in the Chinese family and her brother had previously been diagnosed with JLNS,
and two other members were affected with RWS. The proband was also affected with atrial fibrillation. A
single nucleotide substitution of C to T at nucleotide 965 of KCNQ1 was identified, and the mutation
resulted in the substitution of a threonine residue at codon 322 by a methionine residue (T322M). The
novel heterozygous T322M mutation was identified in two patients with RWS, one member with
borderline QTc, and two normal family members. The two JLNS patients in the family carried the
homozygous T322M mutation. The T322M mutation was not found in 200 Chinese normal controls.
Conclusion: Our results suggest that T322M is a novel mutation that caused RWS with high intrafamilial
variability in the heterozygous carriers and typical JLNS in the homozygous carriers within this Chinese
family. The T322M mutation is the first mutation identified for JLNS in the Chinese population.
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Background
Long QT syndrome (LQTS) is a disorder of cardiac repo-
larization characterized by prolonged QT intervals and
abnormal T waves on surface electrocardiograms (ECG),
torsade de pointes, and sudden death [1-3]. Two forms of
inherited LQTS have been described: Romano-Ward syn-
drome (RWS), which is an autosomal dominant form of
LQTS without sensorineural deafness, and Jervell and
Lange-Nielsen syndrome (JLNS), which is an autosomal
recessive form of LQTS associated with deafness [4-6].
RWS is the most common form of inherited LQTS [7].
More than nine genes have been identified for
RWS:KCNQ1  (or  KvLQT1, LQT1) [8] on chromosome
11p15.5,  KCNH2  (or  HERG, LQT2) on chromosome
7q35-36 [9], SCN5A  (LQT3) on chromosome 3p21
[10,11], Ankyrin-B (LQT4) on chromosome 4q25-27 [12],
KCNE1 (LQT5) on chromosome 21q22 [13,14], KCNE2
(LQT6) on chromosome 21q22 [15], KCNJ2  (LQT7)
17q23.1 [16], CACNA1C  (LQT8) on chromosome
12p13.3 [17], and CAV3 (LQT9) on chromosome 3p25
[18]. Carriers with mutations in KCNJ2 and CACNA1C
exhibit not only the LQTS phenotype but other pheno-
types as well (designated as Andersen syndrome and Tim-
othy syndrome, respectively) [16,17].
JLNS is a rare autosomal recessive disorder that appears to
have a worse prognosis than RWS [19]. JLNS can be
caused by homozygous or compound heterozygous muta-
tions in either KCNQ1  or  KCNE1  [13,20-27].  KCNQ1
encodes a potassium channel gene with six transmem-
brane domains and forms functional IKs potassium chan-
nels by assembling with minK (encoded by KCNE1) in the
heart [8,28].
In this report, we identified a novel mutation in the
KCNQ1 gene that simultaneously caused RWS and JLNS
within a Chinese family. The results expand the spectrum
of KCNQ1 mutations causing RWS and JLNS.
Results
One three-generation JLN/RWS family was identified in
China and clinically evaluated. The pedigree structure of
the family is shown in Figure 1, and clinical characteristics
for family members are listed in Table 1. The proband
(patient III:1) had been deaf since birth. At 3 years of age,
she was referred for detailed examinations due to syncope.
Since then, she has experienced 11 additional syncopal
episodes, most of which were preceded by exercise and
sport. Current ECG analysis revealed a markedly pro-
longed QTc ranging from 0.520 to 0.608 s (a representa-
tive ECG is shown in Figure 2). She was then diagnosed as
having JLNS (deafness + LQTS). Interestingly, the
proband was also affected with atrial fibrillation. The
proband's brother (patient III:2, Figure 1) was also
affected with deafness and LQTS (JLNS). His QTc ranged
from 0.512 s to 0.627 s, and he had experienced three syn-
copal episodes in the past triggered by exercise and sport.
Their parents had normal hearing and normal ECGs with
a QTc of 0.42 s (father) and 0.43 s (mother). Individual
II:1 had experienced one syncopal episode triggered by
exercise when she was 20 years old. No syncope was iden-
tified for individual II:2, but he had experienced palpita-
tion and dyspnea. The parents' marriage was not
consanguineous.
Further analysis of other family members identified two
other members affected with RWS. Individual II:4 was
clinically diagnosed with LQTS because she had a moder-
ately prolonged QTc of 0.455 s and a medical history of
dyspnea and palpitation. Her mother (I:2, Figure 1) was
also affected with LQTS with a prolonged QTc of 0.487 s.
Both I:2 and II:4 had normal hearing. Individual III:4 was
a male with a borderline QTc of 0.447 s. No stress testing
was performed for III:4 or other family members. Individ-
uals I:1, II:3, and III:3 had a normal QTc of 0.420 s, 0.400
s, and 0.397 s, respectively.
A homozygous C → T transition was identified at nucle-
otide 965 in exon 7 of KCNQ1 in the DNA sample from
the proband (Figure 3). The C to T change resulted in the
Table 1: Genotype-phenotype correlation in the Chinese family with both RWS and JLNS and KCNQ1 mutation T322M
ID Sex/Age Deafness Symptoms QTc (s) Genotype
I:1 M/71 No None 0.420 T322 T322
I:2 F/65 No Chest discomfort 0.487 T322 M322
II:1 F/42 No 1 syncope (trigger, exercise) 0.430 T322 M322
II:2 M/43 No Palpitation, dyspnea 0.420 0.410 0.400 T322 M322
II:3 F/39 No None 0.400 T322 T322
II:4 F/36 No dyspnea, palpitation 0.455 0.454 0.444 T322 M322
III:1 F/17 Yes 12 syncope (trigger, exercise) Atrial fibrillation 0.520 0.608 M322 M322
III:2 M/8 Yes 3 syncope (trigger, exercise) 0.512 0.627 M322 M322
III:3 M/16 No None 0.397 T322 T322
III:4 M/9 No None 0.447 T322 M322BMC Medical Genetics 2008, 9:24 http://www.biomedcentral.com/1471-2350/9/24
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substitution of a threonine residue by a methionine resi-
due at codon 322 (T322M) (Figure 3). The homozygous
T322M mutation was also identified in the proband's
brother (individual III:2, Figure 1). The parents and fam-
ily members II:4 and I:2 were heterozygous for the muta-
tion.
The detection of mutation T322M was further confirmed
by RFLP analysis showing the presence of only the mutant
allele (M322) in the proband and her brother (Figure 1,
Table 1). RFLP analysis also demonstrated that family
members II:1, II:2, I:2, II:4, and III:4 were heterozygous
for the mutation (T322 and M322) and that normal indi-
viduals I:1, II:3, and III:3 carried the wild type T322 allele.
The M322 allele was not identified in 200 normal Chinese
Han nationality controls (data not shown).
Discussion
In this report, we describe a Chinese family in which a het-
erozygous mutation in KCNQ1, T322M, resulted in RWS
whereas the homozygous mutation resulted in JLNS asso-
ciated with LQTS and deafness. Heterozygous mutations
in the KCNQ1  gene have been reported in Chinese
patients with RWS, but no KCNQ1 mutation associated
with JLN has been reported in the Chinese population
[29]. Thus, the T322M is the first KCNQ1 mutation iden-
tified for JLN in the Chinese population.
The penetrance of the phenotype in the family members
with homozygous T322M was complete. The two
homozygous mutation carriers, III:1 and III:2 (Figure 1),
had a markedly prolonged QTc of up to 0.608 s and 0.627
s, respectively, and both had experienced multiple synco-
pal episodes triggered by exercise and sport. These results
are consistent with the finding by Schwartz et al. [24] that
Pedigree structure of the Chinese family with JLNS and RWS Figure 1
Pedigree structure of the Chinese family with JLNS and RWS. The results of RFLP analysis for mutation T322M are shown 
below each symbol. Affected male III:1 and females I:2 and III:2 are indicated with filled squares and circles; normal members 
are indicated with open symbols; individual III:4 with borderline QTc is shown with a gray symbol. QTc for family members is 
shown below each symbol as ms. The three-generation family is notable for the proband (III:1, indicated by an arrow) and her 
brother (III:2), who were affected with deafness and had a severely prolonged QTc.
MW
600
400
300
200
100
(bp)
420 ms 487 ms
I
II
III
12
12 34
12 3 4
430 ms 420 ms 400 ms 455 ms
608 ms 627 ms 397 ms 447 msBMC Medical Genetics 2008, 9:24 http://www.biomedcentral.com/1471-2350/9/24
Page 4 of 7
(page number not for citation purposes)
Representative electrocardiograms (ECG) from members of the Chinese family with LQTS Figure 2
Representative electrocardiograms (ECG) from members of the Chinese family with LQTS. Top, ECG from a normal family 
member (I-1); Middle, ECG from a heterozygous mutation carrier; Bottom, ECG from a homozygous mutation carrier.BMC Medical Genetics 2008, 9:24 http://www.biomedcentral.com/1471-2350/9/24
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JLN is a more severe variant of LQTS than RWS. Interest-
ingly, individual III:1 was affected by both LQTS and atrial
fibrillation. Previously, in a Chinese family with atrial
fibrillation and KCNQ1 mutation S140G, multiple family
members had both LQTS and atrial fibrillation [30]. Fur-
ther studies are needed to determine whether and how the
T322M mutation is associated with atrial fibrillation.
The penetrance of the phenotype of QTc prolongation in
heterozygous mutation carriers was not complete. Two
carriers, II-1 and II-2, had a normal QTc (Table 1, Figure
1). On the other hand, two carriers, I-2 and II:4, were
affected with RWS. The other carrier, III-4, had borderline
QTc prolongation. The molecular mechanism that is
responsible for the intra-familial variability or variable
penetrance of the LQTS phenotype in heterozygous carri-
ers is not clear, but environmental factors and modifying
genes are likely possibilities.
Conclusion
This study identified a novel mutation, T322M, in the
KCNQ1 gene that caused RWS with high intrafamilial var-
iability in the heterozygous carriers and typical JLNS in
the homozygous carriers within a Chinese family. To the
best of our knowledge, T322M is the first mutation iden-
tified for JLNS in the Chinese population.
Methods
Study subjects, clinical diagnosis, and isolation of human 
genomic DNA
The LQTS family was identified in the Henan Province of
China. Informed consent was obtained from all the partic-
ipants or their guardians. This study complied with the
Helsinki Declaration and was approved by the ethics com-
mittee of Huazhong University of Science and Technol-
ogy.
LQTS was diagnosed based on the presence of prolonged
QT intervals as seen on a 12-lead ECG and a medical his-
tory of syncope, dyspnea, and palpitation. The QT interval
was manually measured, and the QTc was calculated
using Bazett's formula for heart rate correction [31]. The
diagnosis of LQTS was based on the work of Schwartz et
al. [32] and others [8,10,11]. Asymptomatic individuals
with a QTc of ≥ 0.47 s and symptomatic individuals (syn-
cope, dyspnea, palpitation) with a QTc ≥ 0.45 s were diag-
nosed with LQTS. Males with a QTc of <0.44 s and females
with a QTc of <0.45 s were considered normal. All others
were diagnosed as having borderline QTc.
Peripheral blood was collected from the participants, and
their total human genomic DNA was isolated using the
DNA Isolation Kit for Mammalian Blood (Roche Diag-
nostic Co., Indianapolis, IN).
Mutational analyses
Mutation screening was performed using direct DNA
sequence analysis. The exons and exon-intorn boundaries
of the KCNQ1 gene were amplified with polymerase chain
reaction (PCR). PCR was performed in a 25-μL volume
containing 50 mmol/L KCl, 10 mmol/L Tris-HCl, pH 8.3,
1.5 mmol/L MgCl2, 0.2 mmol/L of each dNTP, 0.5 μmol/
L of each primer, 1 U of Taq polymerase (TaKaRa Biotech-
Identification of KCNQ1 mutation T322M (T to C substitu- tion at nucleotide 965) Figure 3
Identification of KCNQ1 mutation T322M (T to C substitu-
tion at nucleotide 965). Top, normal sequence; Middle, het-
erozygous T322M mutation with both T and C at nucleotide 
965; Bottom, homozygous T322M mutation.BMC Medical Genetics 2008, 9:24 http://www.biomedcentral.com/1471-2350/9/24
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nology Co.), and 50 ng of genomic DNA. The amplifica-
tion program consisted of one cycle of denaturation at
94°C for 3 min, 35 cycles of 94°C for 30 s, 50°C to 60°C
for 30 s (with different annealing temperatures for differ-
ent primer pairs), 72°C for 1 min, and one cycle of exten-
sion at 72°C for 7 min. Each PCR product was separated
by a 1.5% agarose gel, purified using the QIAquick Gel
Extraction Kit (Qiagen Inc., Valencia, CA) and sequenced
with the forward and reverse primers using the BigDye
Terminator Cycle Sequencing v3.1 kit (Applied Biosys-
tems, Inc.).
Mutation designation was based on the cDNA sequence
for KCNQ1 transcript variant 1 (Genbank accession No.
NM_000218).
Mutation T322M disrupted a MaeI restriction site, which
allowed the restriction fragment length polymorphism
(RFLP) analysis to confirm the mutation in family mem-
bers and to test whether the mutation was present in the
controls. Using PCR, we amplified exon 7 of KCNQ1,
which contained the T322M mutation from all members
of the family as well as 200 unrelated healthy Chinese
individuals of Han nationality. The PCR product was 291
bp in length and the primers were 5'-AGAGTGGT-
GGGTTTGGGTTAG-3' (forward primer) and 5'-GAACG-
TAAGTGGGTCTGCTCA-3' (reverse primer). The PCR
product was digested by two units of MaeI at 65°C over-
night and separated on a 2.5% agarose gel.
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